UV Germi SA

EPA:ALUVI.PA

2.61 (EUR) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q4
Revenue 4.6583.8054.4153.1254.0382.9543.3643.5263.1343.1573.152.6292.7112.3282.5841.1891.1051.1051.1051.0641.0641.0641.0640.8370.8370.8370.837
Cost of Revenue 4.1932.2263.9163.2623.7072.943.5353.2963.1493.092.1661.8512.0161.5021.8080.7880.7920.7920.7920.7610.7610.7610.7610.5340.5340.5340.534
Gross Profit 0.4651.5790.499-0.1370.3310.014-0.1710.23-0.0150.0670.9840.7780.6950.8260.7760.4010.3130.3130.3130.3030.3030.3030.3030.3030.3030.3030.303
Gross Profit Ratio 0.10.4150.113-0.0440.0820.005-0.0510.065-0.0050.0210.3120.2960.2560.3550.30.3370.2830.2830.2830.2850.2850.2850.2850.3620.3620.3620.362
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 000000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000000
SG&A 0.0181.3640.0010.120.0020.0010.0030.0120.0530.0021.0110.4460.8490.9180.770.0070.0160.0160.0160.0110.0110.0110.0110.0160.0160.0160.016
Other Expenses -0.036-0.171-0.046-0.04-0.016-0.014-0.006-0.022-0.009-0.01700000000000000000
Operating Expenses 0.0541.9420.0470.1590.0180.0140.0090.0340.0610.0191.1331.0570.9641.010.850.0070.0160.0160.0160.0110.0110.0110.0110.0160.0160.0160.016
Operating Income 0.411-0.1690.452-0.2960.313-0-0.180.195-0.0760.048-0.143-0.177-0.272-0.181-0.075-0.064-0.083-0.083-0.083-0.041-0.041-0.041-0.0410.0140.0140.0140.014
Operating Income Ratio 0.088-0.0440.102-0.0950.078-0-0.0530.055-0.0240.015-0.045-0.067-0.1-0.078-0.029-0.054-0.075-0.075-0.075-0.039-0.039-0.039-0.0390.0170.0170.0170.017
Total Other Income Expenses Net -0.001-0.1930.037-0.058-0.065-0.848-0.0070.0050.0750.013-0.009-0.104-0.001-0.005-0.002-0.001-0.001-0.001-0.001-0.002-0.002-0.002-0.002-0.002-0.002-0.002-0.002
Income Before Tax 0.411-0.3610.489-0.3550.248-0.848-0.1870.2-0.0020.061-0.151-0.281-0.273-0.186-0.077-0.066-0.085-0.085-0.085-0.043-0.043-0.043-0.0430.0120.0120.0120.012
Income Before Tax Ratio 0.088-0.0950.111-0.1130.061-0.287-0.0550.057-0.0010.019-0.048-0.107-0.101-0.08-0.03-0.055-0.077-0.077-0.077-0.04-0.04-0.04-0.040.0140.0140.0140.014
Income Tax Expense -0.0710.077-0.085-0.112-0.061-0.057-0.109-0.119-0.093-0.0920.0940.1180.0750.0330.044-0.019-0.025-0.025-0.025-0.018-0.018-0.018-0.018-0.022-0.022-0.022-0.022
Net Income 0.482-0.2840.574-0.2430.309-0.792-0.0780.3190.0910.153-0.057-0.163-0.198-0.153-0.033-0.047-0.06-0.06-0.06-0.025-0.025-0.025-0.0250.0340.0340.0340.034
Net Income Ratio 0.103-0.0750.13-0.0780.076-0.268-0.0230.090.0290.048-0.018-0.062-0.073-0.066-0.013-0.039-0.054-0.054-0.054-0.023-0.023-0.023-0.0230.040.040.040.04
EPS 0.15-0.090.18-0.0780.099-0.31-0.030.120.0360.06-0.022-0.064-0.077-0.042-0.023-0.018-0.026-0.026-0.026-0.011-0.011-0.011-0.0110.0150.0150.0150.015
EPS Diluted 0.15-0.090.18-0.0780.099-0.31-0.030.120.0360.06-0.022-0.064-0.077-0.042-0.023-0.018-0.026-0.026-0.026-0.011-0.011-0.011-0.0110.0150.0150.0150.015
EBITDA 0.6740.0090.614-0.1410.4710.167-0.0340.3470.0410.156-0.041-0.076-0.18-0.21-0.001-0.028-0.055-0.055-0.055-0.02-0.02-0.02-0.020.0250.0250.0250.025
EBITDA Ratio 0.1450.0020.139-0.0450.1170.057-0.010.0980.0130.049-0.013-0.029-0.066-0.09-0-0.024-0.049-0.049-0.049-0.019-0.019-0.019-0.0190.030.030.030.03